Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment
- PMID: 20363135
- DOI: 10.1016/j.breast.2010.03.008
Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment
Comment on
-
Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies.Gynecol Oncol. 2009 Mar;112(3):605-9. doi: 10.1016/j.ygyno.2008.11.029. Epub 2009 Jan 12. Gynecol Oncol. 2009. PMID: 19136147
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical